Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Does not alter management of myeloproliferative neoplasms; leaves open HERV-K's pathogenic role pending higher-level evidence.
We have previously demonstrated the presence of a reverse transcriptase-like enzyme in retroviral particles from patients with essential thrombocythemia, polycythemia vera, and chronic myelogenous leukemia. It was subsequently shown that the human genome contains 50 copies of HERV-K. HERV-K is a human endogenous class I retroviral element that contains gag, pol, and env open reading frames. Using both reverse transcriptase-polymerase chain reaction and ribonuclease protection assays, it is demonstrated that the HERV-K pol is expressed in human blood leukocytes. The data indicates that this expression is restricted in CML white cells and is the result of gene regulation.
No takes yet. Share an insight, caveat, or question.
Brodsky et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: